Direct and indirect regulation of fetal globin transcript by RNA-binding protein IGF2BP1
Abstract
Despite extensive investigation, the molecular control of developmental hemoglobin expression remains incompletely elucidated. Hemoglobin switching is controlled by transcription factors, miRNAs, and RNA-binding proteins (RBPs) that enforce gene regulatory changes through development. Here we examine the role of the heterochronically silenced N6 methyladenosine (m6A) RNA-binding protein IGF2BP1 that was previously described to regulate HBG1/2 indirectly by suppressing BCL11A expression through an unknown mechanism. We find that IGF2BP1 binds and activates HIC2, itself a BCL11A repressor. Furthermore, we identify that IGF2BP1 plays a BCL11A-independent role by direct binding to HBG1/2 to promote its translation. Stop codon-proximal m6A-modified coding sequences within HBG2 transcripts are necessary and sufficient for direct positive regulation mediated by IGF2BP1. This work deepens the mechanistic understanding of hemoglobin switching and suggests a physical relationship between heterochronic RBPs and globin transcripts.
Article Details
Authors (11)
Steven Coyne
Boston Children's Hospital, Boston, Massachusetts, United States
GueHo Hwang
Boston Children's Hospital, United States
Ting Wu
Children’s Hospital, Zhejiang University School of Medicine
Mir Hossain
Divya S Vinjamur
Boston Children's Hospital, Boston, Massachusetts, United States
Marlena Starrs
Jing Zeng
Felicia Andresen
Dept. of Hematology/Oncology, Boston Children's Hospital, United States
Ashley Elizabeth Gutierrez
Boston Children's Hospital, Boston, Massachusetts, United States
Akiko Shimamura
Dana Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School, Boston, Massachusetts, United States
Daniel E Bauer
Boston Children's Hospital, Boston, Massachusetts, United States